A carregar...

Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans

BACKGROUND: The cannabinoid (CB) system is a rational novel target for treating opioid dependence, a significant public health problem around the world. This proof-of-concept study examined the potential efficacy of a CB(1) receptor partial agonist, dronabinol, in relieving signs and symptoms of opi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Alcohol Depend
Main Authors: Lofwall, Michelle R., Babalonis, Shanna, Nuzzo, Paul A., Elayi, Samy Claude, Walsh, Sharon L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910823/
https://ncbi.nlm.nih.gov/pubmed/27234658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2016.05.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!